Glaukos (GKOS) Gets a Buy from Needham
In a report released today, David Saxon from Needham reiterated a Buy rating on Glaukos (GKOS – Research Report), with a price target of $65.00. The company’s shares closed yesterday at $48.82.Saxon covers the Healthcare s…
on TipRanks.com
Read the original article